Related Experiment Video
Updated: Jun 22, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Contemporary management of hypertension--how to optimize therapy
Steve Leung1, Debabrata Mukherjee
1University of Kentucky, Lexington, Kentucky 40536-0200, USA.
Insights
High blood pressure (BP) significantly increases cardiovascular disease (CVD) risk. Effective management through lifestyle changes and medications is crucial for preventing premature death and improving patient outcomes.
Area of Science:
- Cardiology
- Public Health
- Pharmacology
Background:
- Epidemiological studies confirm a strong link between blood pressure (BP) and cardiovascular disease (CVD) risk.
- Systolic blood pressure (SBP) is a key determinant of CVD risk.
- The World Health Organization (WHO) identifies high BP as a major preventable cause of premature death globally.
Purpose of the Study:
- To review the classification of BP stages.
- To discuss therapeutic goals and lifestyle modifications for BP management.
- To outline optimal BP control strategies for individual patients.
Main Methods:
- Review of epidemiological data on BP and CVD.
- Analysis of safety and effectiveness data for various BP-lowering drug classes.
- Discussion of clinical guidelines for hypertension management.
Main Results:
- Multiple drug classes, including ACE-Is, ARBs, CCBs, and diuretics, are effective for lowering BP.
- Lifestyle modifications play a vital role in BP management.
- Tailored BP control strategies are essential for individual patient care.
Conclusions:
- Optimal detection and treatment of hypertension can significantly reduce CVD risk.
- Comprehensive management involving lifestyle changes and pharmacotherapy is key.
- Controlling blood pressure is a critical public health objective.
Abstract:
Epidemiological data have demonstrated a strong relationship between blood pressure (BP) and cardiovascular disease (CVD) risk and have shown the importance of systolic BP (SBP) as a determinant of such risk. The importance of BP as a risk factor has been further emphasized by a World Health Organization (WHO) report which identified high BP as one of the most important preventable causes of premature morbidity and mortality in developed and developing countries. There is now data available on the safety and effectiveness of different classes of BP-lowering drugs, including diuretics, angiotensin-converting enzyme inhibitors (ACE-Is), dihydropyridine and non-dihydropyridine calcium channel blockers (CCBs), beta-blockers and angiotensin receptor blockers (ARBs). In this review we discuss classification of BP stages, goal of therapy, lifestyle modifications and optimal BP control in individual patients. The detection and optimal treatment of hypertension is likely to significantly ameliorate CVD risk.
Related Concept Videos
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension V: Nursing Management
Hypertension and Regulation of Blood Pressure
Heart Failure V: Medical Management
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Atherosclerosis III: Management